Vaccine shield tested in chronically ill
NCT ID NCT05313087
First seen Apr 23, 2026 · Last updated Jun 06, 2026 · Updated 10 times
Summary
This study looked at how well the COVID-19 vaccine works over time in 360 adults and children with chronic lung or other medical conditions. Researchers measured immune markers like antibodies every 3 months for 18 months after vaccination. The goal was to understand how long protection lasts in these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Jewish Health
Denver, Colorado, 80206, United States
Conditions
Explore the condition pages connected to this study.